查看購物車
  • English
  • Japanese
  • Korean
封面
市場調查報告書
商品編碼
2032544

犬異位性皮膚炎市場報告：按藥物類別、給藥途徑、分銷管道和地區分類（2026-2034 年）

Canine Atopic Dermatitis Market Report by Drug Class Type, Route of Administration, Distribution Channel, and Region 2026-2034
出版日期: | 出版商: IMARC | 英文 141 Pages | 商品交期: 2-3個工作天內

價格

2025年，全球犬類異位性皮膚炎市場規模達27億美元。展望未來，IMARC Group預測，從2026年到2034年，該市場將以12.58%的複合年成長率成長，到2034年達到82億美元。

犬異位性皮膚炎（CAD）是一種由花粉、室內灰塵、昆蟲叮咬、草和食物成分等過敏原引起的犬類過敏性皮膚病。它具有遺傳傾向，通常在6個月至3歲的犬隻中發病。症狀主要出現在腹部、口腔、眼睛、趾間皮膚、耳朵、腕部、肘部和會陰部。 CAD的特徵是多種症狀，包括過度抓癢、發炎以及爪子、腋窩和臉部周圍的搔癢。治療方法包括使用免疫抑制劑、單株抗體和糖皮質激素，可透過口服、注射和外用給藥。已知此病在德國牧羊犬、拉布拉多犬、金毛尋回犬和巴哥犬中發生率很高。

犬類異位性皮膚炎市場趨勢：

全球寵物犬冠狀動脈疾病（CAD）發生率的不斷上升是推動市場前景光明的主要因素之一。這被認為與環境條件的變化、空氣污染加劇以及長期接觸過敏原有關。此外，飼主對CAD早期症狀和徵兆（如皮膚發紅、油膩和酵母樣氣味）的認知和關注度不斷提高，也促進了市場成長。單株抗體在CAD治療中的廣泛應用也推動了市場成長。這些抗體有助於誘導必要的免疫反應並抑制疾病進展。因此，致力於改善動物照護的獸醫、醫院和診所數量的增加也對市場成長產生了積極影響。其他預計推動市場成長的因素包括政府為限制人類藥物在動物中的仿單標示外適應症使用而採取的各項措施，以及獸醫領域的大量研發投入。

本報告解答的主要問題：

  • 全球犬類異位性皮膚炎市場迄今的發展趨勢是什麼？預計未來幾年將如何發展？
  • COVID-19 對全球犬類異位性皮膚炎市場有何影響？
  • 主要區域市場有哪些？
  • 藥物市場是如何依類別細分的？
  • 依行政途徑分類的市場區隔如何？
  • 按分銷管道分類的市場區隔如何？
  • 該產業價值鏈包含哪些不同階段？
  • 該行業的主要促進因素和挑戰是什麼？
  • 全球犬異位性皮膚炎市場的結構是怎麼樣的？主要參與者有哪些？
  • 這個行業的競爭有多激烈？

目錄

第1章：序言

第2章：調查方法

  • 調查目的
  • 相關利益者
  • 數據來源
    • 主要訊息
    • 次要訊息
  • 市場估值
    • 自下而上的方法
    • 自上而下的方法
  • 預測方法

第3章執行摘要

第4章：引言

第5章：全球犬異位性皮膚炎市場

  • 市場概覽
  • 市場表現
  • 新冠疫情的影響
  • 市場預測

第6章 市場區隔：依藥物類別分類

  • 糖皮質激素
  • 免疫抑制劑
  • 單株抗體
  • 其他

第7章 市場區隔：依給藥途徑

  • 外用
  • 口服
  • 注射藥物

第8章 市場區隔：依分銷通路分類

  • 動物醫院
  • 寵物診所
  • 藥局/藥局
  • 其他

第9章 市場區隔：依地區分類

  • 北美洲
    • 美國
    • 加拿大
  • 亞太地區
    • 中國
    • 日本
    • 印度
    • 韓國
    • 澳洲
    • 印尼
    • 其他
  • 歐洲
    • 德國
    • 法國
    • 英國
    • 義大利
    • 西班牙
    • 俄羅斯
    • 其他
  • 拉丁美洲
    • 巴西
    • 墨西哥
    • 其他
  • 中東和非洲

第10章 SWOT 分析

第11章：價值鏈分析

第12章：波特五力分析

第13章：價格分析

第14章 競爭格局

  • 市場結構
  • 大公司
  • 主要公司簡介
    • AB Science
    • Bimeda Inc.
    • Bioceltix SA
    • Boehringer Ingelheim International GmbH
    • Ceva Sante Animale
    • Dechra Pharmaceuticals PLC
    • Elanco Animal Health Incorporated
    • Phibro Animal Health Corporation
    • Toray Industries Inc.
    • Vetoquinol SA
    • Virbac
    • Zoetis Inc.
Product Code: SR112026A4700

The global canine atopic dermatitis market size reached USD 2.7 Billion in 2025. Looking forward, IMARC Group expects the market to reach USD 8.2 Billion by 2034, exhibiting a growth rate (CAGR) of 12.58% during 2026-2034.

Canine atopic dermatitis (CAD) is an allergic skin disease in dogs caused by allergens, such as pollens, house dust, insect bites, grass and food ingredients. It is an inherited predisposition that generally affects dogs aged between six months to three years. It commonly affects the ventral abdomen, mouth, eyes, interdigital skin, ear pinnae, carpal, elbow and perineal area of the animals. CAD is characterized by various symptoms, such as excessive scratching, inflammation and itching around paws, underarms and face. It can be treated by immuno-suppressants, monoclonal anatomy and glucocorticoids. They can be administered through oral, injectables and topical medications. It is known to be highly prevalent in German shepherds, Labradors, golden retrievers and pugs.

Canine Atopic Dermatitis Market Trends:

The increasing occurrence of CAD in domesticated dogs across the globe is one of the key factors creating a positive outlook for the market. This can be attributed to the changing environmental conditions, rising air pollution levels and prolonged exposure to allergens. Moreover, the increasing concerns and rising awareness among pet owners regarding early symptoms and signs of CAD, such as redness, greasy skin and yeasty smell, are providing a thrust to the market growth. Additionally, the widespread adoption of monoclonal antibodies for the treatment of the disease is favoring the market growth. These antibodies aid in directing the required immune response and calming the spread of the disease. In line with this, the increasing number of veterinary practitioners, hospitals and clinics dedicated to providing improved care for animals is positively impacting the market growth. Other factors, including the implementation of various government initiatives to restrict the usage of off-label human drugs on animals, along with extensive research and development (R&D) in the field of veterinary sciences, are anticipated to drive the market toward growth.

Key Market Segmentation:

The publisher provides an analysis of the key trends in each sub-segment of the global canine atopic dermatitis market report, along with forecasts at the global, regional and country level from 2026-2034. Our report has categorized the market based on drug class type, route of administration and distribution channel.

Breakup by Drug Class Type:

  • Glucocorticoids
  • Immunosuppressants
  • Monoclonal Antibody
  • Others

Breakup by Route of Administration:

  • Topical
  • Oral
  • Injectable

Breakup by Distribution Channel:

  • Veterinary Hospitals
  • Pet Clinics
  • Pharmacies and Drugstores
  • Others

Breakup by Region:

  • North America
  • United States
  • Canada
  • Asia-Pacific
  • China
  • Japan
  • India
  • South Korea
  • Australia
  • Indonesia
  • Others
  • Europe
  • Germany
  • France
  • United Kingdom
  • Italy
  • Spain
  • Russia
  • Others
  • Latin America
  • Brazil
  • Mexico
  • Others
  • Middle East and Africa

Competitive Landscape:

The competitive landscape of the industry has also been examined along with the profiles of the key players being AB Science, Bimeda Inc., Bioceltix SA, Boehringer Ingelheim International GmbH, Ceva Sante Animale, Dechra Pharmaceuticals PLC, Elanco Animal Health Incorporated, Phibro Animal Health Corporation, Toray Industries Inc., Vetoquinol S.A., Virbac and Zoetis Inc.

Key Questions Answered in This Report:

  • How has the global canine atopic dermatitis market performed so far and how will it perform in the coming years?
  • What has been the impact of COVID-19 on the global canine atopic dermatitis market?
  • What are the key regional markets?
  • What is the breakup of the market based on the drug class type?
  • What is the breakup of the market based on the route of administration?
  • What is the breakup of the market based on the distribution channel?
  • What are the various stages in the value chain of the industry?
  • What are the key driving factors and challenges in the industry?
  • What is the structure of the global canine atopic dermatitis market and who are the key players?
  • What is the degree of competition in the industry?

Table of Contents

1 Preface

2 Scope and Methodology

  • 2.1 Objectives of the Study
  • 2.2 Stakeholders
  • 2.3 Data Sources
    • 2.3.1 Primary Sources
    • 2.3.2 Secondary Sources
  • 2.4 Market Estimation
    • 2.4.1 Bottom-Up Approach
    • 2.4.2 Top-Down Approach
  • 2.5 Forecasting Methodology

3 Executive Summary

4 Introduction

  • 4.1 Overview
  • 4.2 Key Industry Trends

5 Global Canine Atopic Dermatitis Market

  • 5.1 Market Overview
  • 5.2 Market Performance
  • 5.3 Impact of COVID-19
  • 5.4 Market Forecast

6 Market Breakup by Drug Class Type

  • 6.1 Glucocorticoids
    • 6.1.1 Market Trends
    • 6.1.2 Market Forecast
  • 6.2 Immunosuppressants
    • 6.2.1 Market Trends
    • 6.2.2 Market Forecast
  • 6.3 Monoclonal Antibody
    • 6.3.1 Market Trends
    • 6.3.2 Market Forecast
  • 6.4 Others
    • 6.4.1 Market Trends
    • 6.4.2 Market Forecast

7 Market Breakup by Route of Administration

  • 7.1 Topical
    • 7.1.1 Market Trends
    • 7.1.2 Market Forecast
  • 7.2 Oral
    • 7.2.1 Market Trends
    • 7.2.2 Market Forecast
  • 7.3 Injectable
    • 7.3.1 Market Trends
    • 7.3.2 Market Forecast

8 Market Breakup by Distribution Channel

  • 8.1 Veterinary Hospitals
    • 8.1.1 Market Trends
    • 8.1.2 Market Forecast
  • 8.2 Pet Clinics
    • 8.2.1 Market Trends
    • 8.2.2 Market Forecast
  • 8.3 Pharmacies and Drugstores
    • 8.3.1 Market Trends
    • 8.3.2 Market Forecast
  • 8.4 Others
    • 8.4.1 Market Trends
    • 8.4.2 Market Forecast

9 Market Breakup by Region

  • 9.1 North America
    • 9.1.1 United States
      • 9.1.1.1 Market Trends
      • 9.1.1.2 Market Forecast
    • 9.1.2 Canada
      • 9.1.2.1 Market Trends
      • 9.1.2.2 Market Forecast
  • 9.2 Asia-Pacific
    • 9.2.1 China
      • 9.2.1.1 Market Trends
      • 9.2.1.2 Market Forecast
    • 9.2.2 Japan
      • 9.2.2.1 Market Trends
      • 9.2.2.2 Market Forecast
    • 9.2.3 India
      • 9.2.3.1 Market Trends
      • 9.2.3.2 Market Forecast
    • 9.2.4 South Korea
      • 9.2.4.1 Market Trends
      • 9.2.4.2 Market Forecast
    • 9.2.5 Australia
      • 9.2.5.1 Market Trends
      • 9.2.5.2 Market Forecast
    • 9.2.6 Indonesia
      • 9.2.6.1 Market Trends
      • 9.2.6.2 Market Forecast
    • 9.2.7 Others
      • 9.2.7.1 Market Trends
      • 9.2.7.2 Market Forecast
  • 9.3 Europe
    • 9.3.1 Germany
      • 9.3.1.1 Market Trends
      • 9.3.1.2 Market Forecast
    • 9.3.2 France
      • 9.3.2.1 Market Trends
      • 9.3.2.2 Market Forecast
    • 9.3.3 United Kingdom
      • 9.3.3.1 Market Trends
      • 9.3.3.2 Market Forecast
    • 9.3.4 Italy
      • 9.3.4.1 Market Trends
      • 9.3.4.2 Market Forecast
    • 9.3.5 Spain
      • 9.3.5.1 Market Trends
      • 9.3.5.2 Market Forecast
    • 9.3.6 Russia
      • 9.3.6.1 Market Trends
      • 9.3.6.2 Market Forecast
    • 9.3.7 Others
      • 9.3.7.1 Market Trends
      • 9.3.7.2 Market Forecast
  • 9.4 Latin America
    • 9.4.1 Brazil
      • 9.4.1.1 Market Trends
      • 9.4.1.2 Market Forecast
    • 9.4.2 Mexico
      • 9.4.2.1 Market Trends
      • 9.4.2.2 Market Forecast
    • 9.4.3 Others
      • 9.4.3.1 Market Trends
      • 9.4.3.2 Market Forecast
  • 9.5 Middle East and Africa
    • 9.5.1 Market Trends
    • 9.5.2 Market Breakup by Country
    • 9.5.3 Market Forecast

10 SWOT Analysis

  • 10.1 Overview
  • 10.2 Strengths
  • 10.3 Weaknesses
  • 10.4 Opportunities
  • 10.5 Threats

11 Value Chain Analysis

12 Porters Five Forces Analysis

  • 12.1 Overview
  • 12.2 Bargaining Power of Buyers
  • 12.3 Bargaining Power of Suppliers
  • 12.4 Degree of Competition
  • 12.5 Threat of New Entrants
  • 12.6 Threat of Substitutes

13 Price Analysis

14 Competitive Landscape

  • 14.1 Market Structure
  • 14.2 Key Players
  • 14.3 Profiles of Key Players
    • 14.3.1 AB Science
      • 14.3.1.1 Company Overview
      • 14.3.1.2 Product Portfolio
      • 14.3.1.3 Financials
    • 14.3.2 Bimeda Inc.
      • 14.3.2.1 Company Overview
      • 14.3.2.2 Product Portfolio
    • 14.3.3 Bioceltix SA
      • 14.3.3.1 Company Overview
      • 14.3.3.2 Product Portfolio
    • 14.3.4 Boehringer Ingelheim International GmbH
      • 14.3.4.1 Company Overview
      • 14.3.4.2 Product Portfolio
    • 14.3.5 Ceva Sante Animale
      • 14.3.5.1 Company Overview
      • 14.3.5.2 Product Portfolio
    • 14.3.6 Dechra Pharmaceuticals PLC
      • 14.3.6.1 Company Overview
      • 14.3.6.2 Product Portfolio
      • 14.3.6.3 Financials
    • 14.3.7 Elanco Animal Health Incorporated
      • 14.3.7.1 Company Overview
      • 14.3.7.2 Product Portfolio
      • 14.3.7.3 Financials
    • 14.3.8 Phibro Animal Health Corporation
      • 14.3.8.1 Company Overview
      • 14.3.8.2 Product Portfolio
      • 14.3.8.3 Financials
      • 14.3.8.4 SWOT Analysis
    • 14.3.9 Toray Industries Inc.
      • 14.3.9.1 Company Overview
      • 14.3.9.2 Product Portfolio
      • 14.3.9.3 Financials
      • 14.3.9.4 SWOT Analysis
    • 14.3.10 Vetoquinol S.A.
      • 14.3.10.1 Company Overview
      • 14.3.10.2 Product Portfolio
      • 14.3.10.3 Financials
    • 14.3.11 Virbac
      • 14.3.11.1 Company Overview
      • 14.3.11.2 Product Portfolio
      • 14.3.11.3 Financials
      • 14.3.11.4 SWOT Analysis
    • 14.3.12 Zoetis Inc.
      • 14.3.12.1 Company Overview
      • 14.3.12.2 Product Portfolio
      • 14.3.12.3 Financials
      • 14.3.12.4 SWOT Analysis

List of Figures

  • Figure 1: Global: Canine Atopic Dermatitis Market: Major Drivers and Challenges
  • Figure 2: Global: Canine Atopic Dermatitis Market: Sales Value (in Billion USD), 2020-2025
  • Figure 3: Global: Canine Atopic Dermatitis Market Forecast: Sales Value (in Billion USD), 2026-2034
  • Figure 4: Global: Canine Atopic Dermatitis Market: Breakup by Drug Class Type (in %), 2025
  • Figure 5: Global: Canine Atopic Dermatitis Market: Breakup by Route of Administration (in %), 2025
  • Figure 6: Global: Canine Atopic Dermatitis Market: Breakup by Distribution Channel (in %), 2025
  • Figure 7: Global: Canine Atopic Dermatitis Market: Breakup by Region (in %), 2025
  • Figure 8: Global: Canine Atopic Dermatitis (Glucocorticoids) Market: Sales Value (in Million USD), 2020 & 2025
  • Figure 9: Global: Canine Atopic Dermatitis (Glucocorticoids) Market Forecast: Sales Value (in Million USD), 2026-2034
  • Figure 10: Global: Canine Atopic Dermatitis (Immunosuppressants) Market: Sales Value (in Million USD), 2020 & 2025
  • Figure 11: Global: Canine Atopic Dermatitis (Immunosuppressants) Market Forecast: Sales Value (in Million USD), 2026-2034
  • Figure 12: Global: Canine Atopic Dermatitis (Monoclonal Antibody) Market: Sales Value (in Million USD), 2020 & 2025
  • Figure 13: Global: Canine Atopic Dermatitis (Monoclonal Antibody) Market Forecast: Sales Value (in Million USD), 2026-2034
  • Figure 14: Global: Canine Atopic Dermatitis (Other Drug Class Types) Market: Sales Value (in Million USD), 2020 & 2025
  • Figure 15: Global: Canine Atopic Dermatitis (Other Drug Class Types) Market Forecast: Sales Value (in Million USD), 2026-2034
  • Figure 16: Global: Canine Atopic Dermatitis (Topical) Market: Sales Value (in Million USD), 2020 & 2025
  • Figure 17: Global: Canine Atopic Dermatitis (Topical) Market Forecast: Sales Value (in Million USD), 2026-2034
  • Figure 18: Global: Canine Atopic Dermatitis (Oral) Market: Sales Value (in Million USD), 2020 & 2025
  • Figure 19: Global: Canine Atopic Dermatitis (Oral) Market Forecast: Sales Value (in Million USD), 2026-2034
  • Figure 20: Global: Canine Atopic Dermatitis (Injectable) Market: Sales Value (in Million USD), 2020 & 2025
  • Figure 21: Global: Canine Atopic Dermatitis (Injectable) Market Forecast: Sales Value (in Million USD), 2026-2034
  • Figure 22: Global: Canine Atopic Dermatitis (Veterinary Hospitals) Market: Sales Value (in Million USD), 2020 & 2025
  • Figure 23: Global: Canine Atopic Dermatitis (Veterinary Hospitals) Market Forecast: Sales Value (in Million USD), 2026-2034
  • Figure 24: Global: Canine Atopic Dermatitis (Pet Clinics) Market: Sales Value (in Million USD), 2020 & 2025
  • Figure 25: Global: Canine Atopic Dermatitis (Pet Clinics) Market Forecast: Sales Value (in Million USD), 2026-2034
  • Figure 26: Global: Canine Atopic Dermatitis (Pharmacies and Drugstores) Market: Sales Value (in Million USD), 2020 & 2025
  • Figure 27: Global: Canine Atopic Dermatitis (Pharmacies and Drugstores) Market Forecast: Sales Value (in Million USD), 2026-2034
  • Figure 28: Global: Canine Atopic Dermatitis (Other Distribution Channels) Market: Sales Value (in Million USD), 2020 & 2025
  • Figure 29: Global: Canine Atopic Dermatitis (Other Distribution Channels) Market Forecast: Sales Value (in Million USD), 2026-2034
  • Figure 30: North America: Canine Atopic Dermatitis Market: Sales Value (in Million USD), 2020 & 2025
  • Figure 31: North America: Canine Atopic Dermatitis Market Forecast: Sales Value (in Million USD), 2026-2034
  • Figure 32: United States: Canine Atopic Dermatitis Market: Sales Value (in Million USD), 2020 & 2025
  • Figure 33: United States: Canine Atopic Dermatitis Market Forecast: Sales Value (in Million USD), 2026-2034
  • Figure 34: Canada: Canine Atopic Dermatitis Market: Sales Value (in Million USD), 2020 & 2025
  • Figure 35: Canada: Canine Atopic Dermatitis Market Forecast: Sales Value (in Million USD), 2026-2034
  • Figure 36: Asia-Pacific: Canine Atopic Dermatitis Market: Sales Value (in Million USD), 2020 & 2025
  • Figure 37: Asia-Pacific: Canine Atopic Dermatitis Market Forecast: Sales Value (in Million USD), 2026-2034
  • Figure 38: China: Canine Atopic Dermatitis Market: Sales Value (in Million USD), 2020 & 2025
  • Figure 39: China: Canine Atopic Dermatitis Market Forecast: Sales Value (in Million USD), 2026-2034
  • Figure 40: Japan: Canine Atopic Dermatitis Market: Sales Value (in Million USD), 2020 & 2025
  • Figure 41: Japan: Canine Atopic Dermatitis Market Forecast: Sales Value (in Million USD), 2026-2034
  • Figure 42: India: Canine Atopic Dermatitis Market: Sales Value (in Million USD), 2020 & 2025
  • Figure 43: India: Canine Atopic Dermatitis Market Forecast: Sales Value (in Million USD), 2026-2034
  • Figure 44: South Korea: Canine Atopic Dermatitis Market: Sales Value (in Million USD), 2020 & 2025
  • Figure 45: South Korea: Canine Atopic Dermatitis Market Forecast: Sales Value (in Million USD), 2026-2034
  • Figure 46: Australia: Canine Atopic Dermatitis Market: Sales Value (in Million USD), 2020 & 2025
  • Figure 47: Australia: Canine Atopic Dermatitis Market Forecast: Sales Value (in Million USD), 2026-2034
  • Figure 48: Indonesia: Canine Atopic Dermatitis Market: Sales Value (in Million USD), 2020 & 2025
  • Figure 49: Indonesia: Canine Atopic Dermatitis Market Forecast: Sales Value (in Million USD), 2026-2034
  • Figure 50: Others: Canine Atopic Dermatitis Market: Sales Value (in Million USD), 2020 & 2025
  • Figure 51: Others: Canine Atopic Dermatitis Market Forecast: Sales Value (in Million USD), 2026-2034
  • Figure 52: Europe: Canine Atopic Dermatitis Market: Sales Value (in Million USD), 2020 & 2025
  • Figure 53: Europe: Canine Atopic Dermatitis Market Forecast: Sales Value (in Million USD), 2026-2034
  • Figure 54: Germany: Canine Atopic Dermatitis Market: Sales Value (in Million USD), 2020 & 2025
  • Figure 55: Germany: Canine Atopic Dermatitis Market Forecast: Sales Value (in Million USD), 2026-2034
  • Figure 56: France: Canine Atopic Dermatitis Market: Sales Value (in Million USD), 2020 & 2025
  • Figure 57: France: Canine Atopic Dermatitis Market Forecast: Sales Value (in Million USD), 2026-2034
  • Figure 58: United Kingdom: Canine Atopic Dermatitis Market: Sales Value (in Million USD), 2020 & 2025
  • Figure 59: United Kingdom: Canine Atopic Dermatitis Market Forecast: Sales Value (in Million USD), 2026-2034
  • Figure 60: Italy: Canine Atopic Dermatitis Market: Sales Value (in Million USD), 2020 & 2025
  • Figure 61: Italy: Canine Atopic Dermatitis Market Forecast: Sales Value (in Million USD), 2026-2034
  • Figure 62: Spain: Canine Atopic Dermatitis Market: Sales Value (in Million USD), 2020 & 2025
  • Figure 63: Spain: Canine Atopic Dermatitis Market Forecast: Sales Value (in Million USD), 2026-2034
  • Figure 64: Russia: Canine Atopic Dermatitis Market: Sales Value (in Million USD), 2020 & 2025
  • Figure 65: Russia: Canine Atopic Dermatitis Market Forecast: Sales Value (in Million USD), 2026-2034
  • Figure 66: Others: Canine Atopic Dermatitis Market: Sales Value (in Million USD), 2020 & 2025
  • Figure 67: Others: Canine Atopic Dermatitis Market Forecast: Sales Value (in Million USD), 2026-2034
  • Figure 68: Latin America: Canine Atopic Dermatitis Market: Sales Value (in Million USD), 2020 & 2025
  • Figure 69: Latin America: Canine Atopic Dermatitis Market Forecast: Sales Value (in Million USD), 2026-2034
  • Figure 70: Brazil: Canine Atopic Dermatitis Market: Sales Value (in Million USD), 2020 & 2025
  • Figure 71: Brazil: Canine Atopic Dermatitis Market Forecast: Sales Value (in Million USD), 2026-2034
  • Figure 72: Mexico: Canine Atopic Dermatitis Market: Sales Value (in Million USD), 2020 & 2025
  • Figure 73: Mexico: Canine Atopic Dermatitis Market Forecast: Sales Value (in Million USD), 2026-2034
  • Figure 74: Others: Canine Atopic Dermatitis Market: Sales Value (in Million USD), 2020 & 2025
  • Figure 75: Others: Canine Atopic Dermatitis Market Forecast: Sales Value (in Million USD), 2026-2034
  • Figure 76: Middle East and Africa: Canine Atopic Dermatitis Market: Sales Value (in Million USD), 2020 & 2025
  • Figure 77: Middle East and Africa: Canine Atopic Dermatitis Market: Breakup by Country (in %), 2025
  • Figure 78: Middle East and Africa: Canine Atopic Dermatitis Market Forecast: Sales Value (in Million USD), 2026-2034
  • Figure 79: Global: Canine Atopic Dermatitis Industry: SWOT Analysis
  • Figure 80: Global: Canine Atopic Dermatitis Industry: Value Chain Analysis
  • Figure 81: Global: Canine Atopic Dermatitis Industry: Porter's Five Forces Analysis

List of Tables

  • Table 1: Global: Canine Atopic Dermatitis Market: Key Industry Highlights, 2025 and 2034
  • Table 2: Global: Canine Atopic Dermatitis Market Forecast: Breakup by Drug Class Type (in Million USD), 2026-2034
  • Table 3: Global: Canine Atopic Dermatitis Market Forecast: Breakup by Route of Administration (in Million USD), 2026-2034
  • Table 4: Global: Canine Atopic Dermatitis Market Forecast: Breakup by Distribution Channel (in Million USD), 2026-2034
  • Table 5: Global: Canine Atopic Dermatitis Market Forecast: Breakup by Region (in Million USD), 2026-2034
  • Table 6: Global: Canine Atopic Dermatitis Market: Competitive Structure
  • Table 7: Global: Canine Atopic Dermatitis Market: Key Players